Babak Parviz is the Co-Founder and CEO of NewDays, a Seattle-based AI-powered cognitive health company developing breakthrough treatments for mild cognitive impairment and early dementia.

Babak earned a Ph.D. in Electrical Engineering from the University of Michigan and completed a postdoctoral fellowship in Chemistry and Chemical Biology at Harvard University.

Babak founded and led the Google Glass team at Google X, co-founded a smart contact lens program that became a Novartis partnership, and launched a robotic surgery program later spun out as Verb Surgical and acquired by Johnson and Johnson.

As VP at Amazon for over eight years, Babak founded and led Amazon's Grand Challenge division, driving the company's expansion into healthcare, diagnostics, and machine learning for biotech, during a period when Amazon grew nearly 10X to become a trillion-dollar company.

NewDays has raised $11.5M in seed funding from General Catalyst and Madrona Venture Group, and its AI companion Sunny is already delivering measurable cognitive improvements to patients across four U.S. states, targeting the 7.2 million Americans living with Alzheimer's.